On 24 July 2026, a meeting was held in the assembly hall of the Analytical Expertise Center of the Ministry of Health of the Republic of Azerbaijan with the management of several major pharmaceutical wholesale companies operating in Azerbaijan and
owning extensive pharmacy chains. The meeting was organized in response to deficiencies identified by the specialists of the Analytical Expertise Center in the use of the Tracking and Tracing System for medicinal products during the circulation of medicines.
During the meeting, participants were provided with detailed information on the most significant issues currently observed in the use of the System. Discussions also focused on the key measures that should be implemented to prevent serious non-compliance and operational deficiencies in the future. The discussions covered both pharmaceutical wholesale enterprises and the pharmacies operating under their management.
As part of the meeting, the purpose and objectives of the Tracking and Tracing System were once again explained in detail to the company executives. It was emphasized that wholesale pharmaceutical companies, as one of the key links in the supply chain from the manufacturer to the end consumer, must ensure the accurate and proper use of the System. Company representatives were informed that establishing effective internal control mechanisms to ensure compliance with regulatory requirements and the uninterrupted exchange of data is one of their highest priorities.
The meeting also addressed the current non-compliance issues identified in the companies’ use of the System, the potential serious consequences of such shortcomings, and the measures required to eliminate them. The companies were instructed to reiterate to all subordinate enterprises the importance of using the Tracking and Tracing System correctly and in full accordance with the established guidelines.
